# PARTIQoL (NCT01617161)

> Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT01617161
- Phase: NA
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Massachusetts General Hospital
- Conditions: Prostate Cancer
- Interventions: Proton Beam Therapy; Intensity Modulated Radiation Therapy
- Enrollment: 454
- Primary outcome: Efficacy of PBT vs. IMRT

## Commentary we found

- X threads: 62
- YouTube: 3
- Podcasts: 2

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=partiqol-nct01617161

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT01617161", "email": "<work email>"}; the inbox owner confirms by the emailed link.